Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways

Neuropharmacology

Volumn 62, Issue 7, 2012, Pages 2363-2372

  Bourque, Mélanie ^a,b   Dluzen, Dean E ^c   Di Paolo, Thérse ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Northeastern Ohio Medical University   (United States)

Author keywords

Akt; Dopamine; Methamphetamine; Neurotoxicity; Sex difference; Striatum

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; ENZYME PHOSPHORYLATION; FEMALE; MALE; MOUSE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TIME; WESTERN BLOTTING;

EID: 84859104780     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.02.009     Document Type: Article

References (57)

1. T. Barrett, T. Xie, Y. Piao, O. Dillon-Carter, G.J. Kargul, M.K. Lim, F.J. Chrest, R. Wersto, D.L. Rowley, M. Juhaszova, L. Zhou, M.P. Vawter, K.G. Becker, C. Cheadle, W.H. Wood 3rd, U.D. McCann, W.J. Freed, M.S. Ko, G.A. Ricaurte, and D.M. Donovan A murine dopamine neuron-specific cDNA library and microarray: increased COX1 expression during methamphetamine neurotoxicity Neurobiol. Dis. 8 2001 822 833 (Pubitemid 33055598)
2. S.D. Bhatt, and D.E. Dluzen Dopamine transporter function differences between male and female CD-1 mice Brain Res. 1035 2005 188 195 (Pubitemid 40250190)
3. M. Bourque, B. Liu, D.E. Dluzen, and T. Di Paolo Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity Biochem. Pharmacol. 74 2007 1413 1423 (Pubitemid 47445443)
4. M. Bourque, B. Liu, D.E. Dluzen, and T. Di Paolo Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways Psychoneuroendocrinology 36 2011 955 969
5. E. Brailoiu, S.L. Dun, G.C. Brailoiu, K. Mizuo, L.A. Sklar, T.I. Oprea, E.R. Prossnitz, and N.J. Dun Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system J. Endocrinol. 193 2007 311 321
6. K. Brami-Cherrier, E. Valjent, M. Garcia, C. Pages, R.A. Hipskind, and J. Caboche Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation J. Neurosci. 22 2002 8911 8921 (Pubitemid 35379061)
7. R.C. Callaghan, J.K. Cunningham, G. Sajeev, and S.J. Kish Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders Mov. Disord. 25 2010 2333 2339
8. S. Callier, M. Morissette, M. Grandbois, D. Pelaprat, and T. Di Paolo Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice Synapse 41 2001 131 138
9. G. Chen, K.A. Bower, C. Ma, S. Fang, C.J. Thiele, and J. Luo Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death Faseb J. 18 2004 1162 1164 (Pubitemid 39561557)
10. P. Cohen, and S. Frame The renaissance of GSK3 Nat. Rev. Mol. Cell Biol. 2 2001 769 776 (Pubitemid 33679839)
11. M. D'Astous, T.M. Gajjar, D.E. Dluzen, and T. Di Paolo Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol Neuroendocrinology 79 2004 296 304 (Pubitemid 39179159)
12. M. D'Astous, K.R. Mickley, D.E. Dluzen, and T. Di Paolo Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice Neuroendocrinology 82 2005 111 120
13. D.E. Dluzen, S. Bhatt, and J.L. McDermott Differences in reserpine-induced striatal dopamine output and content between female and male mice: implications for sex differences in vesicular monoamine transporter 2 function Neuroscience 154 2008 1488 1496
14. D.E. Dluzen, J.L. McDermott, M. Bourque, T. Di Paolo, A.S. Darvesh, A.B. Buletko, and N.J. Laping Markers associated with sex differences in methamphetamine-induced striatal dopamine neurotoxicity Curr. Neuropharmacol. 9 2011 40 44
15. D.E. Dluzen, J.L. McDermott, and A.S. Darvesh Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity Neuroscience 167 2010 985 993
16. M. Enguita, N. DeGregorio-Rocasolano, A. Abad, and R. Trullas Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells Mol. Pharmacol. 67 2005 1237 1246 (Pubitemid 40410424)
17. A.E. Fleckenstein, S. Pogun, F.I. Carroll, and M.J. Kuhar Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride] J. Pharmacol. Exp. Ther. 279 1996 200 206
18. F. Fumagalli, R.R. Gainetdinov, K.J. Valenzano, and M.G. Caron Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter J. Neurosci. 18 1998 4861 4869 (Pubitemid 28285395)
19. F. Fumagalli, R.R. Gainetdinov, Y.M. Wang, K.J. Valenzano, G.W. Miller, and M.G. Caron Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice J. Neurosci. 19 1999 2424 2431 (Pubitemid 29162392)
20. X. Gao, and D.E. Dluzen The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system Brain Res. 892 2001 63 69 (Pubitemid 32126567)
21. B.G. Garcia, Y. Wei, J.A. Moron, R.Z. Lin, J.A. Javitch, and A. Galli Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution Mol. Pharmacol. 68 2005 102 109 (Pubitemid 41002948)
22. S. Gingerich, G.L. Kim, J.A. Chalmers, M.M. Koletar, X. Wang, Y. Wang, and D.D. Belsham Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models Neuroscience 170 2010 54 66
23. T.S. Guillot, K.R. Shepherd, J.R. Richardson, M.Z. Wang, Y. Li, P.C. Emson, and G.W. Miller Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis J. Neurochem. 106 2008 2205 2217
24. G.C. Hadlock, P.W. Chu, E.T. Walters, G.R. Hanson, and A.E. Fleckenstein Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation J. Pharmacol. Exp. Ther. 335 2010 207 212
25. M.A. Hebert, and J.P. O'Callaghan Protein phosphorylation cascades associated with methamphetamine-induced glial activation Ann. N. Y. Acad. Sci. 914 2000 238 262
26. M. Hetman, J.E. Cavanaugh, D. Kimelman, and Z. Xia Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal J. Neurosci. 20 2000 2567 2574 (Pubitemid 30220344)
27. M. Hetman, S.L. Hsuan, A. Habas, M.J. Higgins, and Z. Xia ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons J. Biol. Chem. 277 2002 49577 49584 (Pubitemid 36014397)
28. S. Jayanthi, X. Deng, P.A. Noailles, B. Ladenheim, and J.L. Cadet Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades Faseb J. 18 2004 238 251 (Pubitemid 38186243)
29. J. Ji, J.L. McDermott, and D.E. Dluzen Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice J. Neuroendocrinol. 19 2007 725 731 (Pubitemid 47386546)
30. C.E. Johanson, K.A. Frey, L.H. Lundahl, P. Keenan, N. Lockhart, J. Roll, G.P. Galloway, R.A. Koeppe, M.R. Kilbourn, T. Robbins, and C.R. Schuster Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers Psychopharmacology (Berl) 185 2006 327 338
31. S. Jourdain, M. Morissette, N. Morin, and T. Di Paolo Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice J. Neuroendocrinol. 17 2005 509 517 (Pubitemid 40990692)
32. M. Kilbourn, and K. Frey Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains Eur. J. Pharmacol. 307 1996 227 232 (Pubitemid 26226227)
33. V. Kunnathur, K. Shemisa, B. Liu, T.J. Salvaterra, and D.E. Dluzen Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine Neurotoxicol. Teratol. 28 2006 557 562 (Pubitemid 44708580)
34. M.J. LaVoie, and T.G. Hastings Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine J. Neurosci. 19 1999 1484 1491 (Pubitemid 29088929)
35. D. Lebesgue, M. Traub, M. De Butte-Smith, C. Chen, R.S. Zukin, M.J. Kelly, and A.M. Etgen Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats PLoS One 5 2010 e8642
36. B. Liu, and D. Dluzen New research on methamphetamine abuse (gender differences in methamphetamine effects: review of animal and human studies) T. Walcott, Drug and Alcohol Abuse Research Focus 2007 Nova Science Publishers 1 24
37. B. Liu, and D.E. Dluzen Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system Synapse 60 2006 354 361 (Pubitemid 44215838)
38. B.D. Manning, and L.C. Cantley AKT/PKB signaling: navigating downstream Cell 129 2007 1261 1274 (Pubitemid 46962095)
39. M. Morissette, and T. Di Paolo Sex and estrous cycle variations of rat striatal dopamine uptake sites Neuroendocrinology 58 1993 16 22 (Pubitemid 23279066)
40. J.A. Moron, I. Zakharova, J.V. Ferrer, G.A. Merrill, B. Hope, E.M. Lafer, Z.C. Lin, J.B. Wang, J.A. Javitch, A. Galli, and T.S. Shippenberg Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity J. Neurosci. 23 2003 8480 8488 (Pubitemid 37158747)
41. C.A. Munro, M.E. McCaul, D.F. Wong, L.M. Oswald, Y. Zhou, J. Brasic, H. Kuwabara, A. Kumar, M. Alexander, W. Ye, and G.S. Wand Sex differences in striatal dopamine release in healthy adults Biol. Psychiatry 59 2006 966 974
42. G. Pearson, F. Robinson, T. Beers Gibson, B.E. Xu, M. Karandikar, K. Berman, and M.H. Cobb Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr. Rev. 22 2001 153 183 (Pubitemid 32458157)
43. E.R. Prossnitz, and M. Barton Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER Prostaglandins Other Lipid. Mediat. 89 2009 89 97
44. C.M. Revankar, D.F. Cimino, L.A. Sklar, J.B. Arterburn, and E.R. Prossnitz A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 307 2005 1625 1630 (Pubitemid 40354745)
45. Y. Sekine, Y. Ouchi, G. Sugihara, N. Takei, E. Yoshikawa, K. Nakamura, Y. Iwata, K.J. Tsuchiya, S. Suda, K. Suzuki, M. Kawai, K. Takebayashi, S. Yamamoto, H. Matsuzaki, T. Ueki, N. Mori, M.S. Gold, and J.L. Cadet Methamphetamine causes microglial activation in the brains of human abusers J. Neurosci. 28 2008 5756 5761
46. Y. Sekine, Y. Ouchi, N. Takei, E. Yoshikawa, K. Nakamura, M. Futatsubashi, H. Okada, Y. Minabe, K. Suzuki, Y. Iwata, K.J. Tsuchiya, H. Tsukada, M. Iyo, and N. Mori Brain serotonin transporter density and aggression in abstinent methamphetamine abusers Arch. Gen. Psychiatry 63 2006 90 100 (Pubitemid 43037473)
47. X. Shi, and J.F. McGinty Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum Neuroscience 138 2006 1289 1298 (Pubitemid 43363545)
48. G.E. Torres, R.R. Gainetdinov, and M.G. Caron Plasma membrane monoamine transporters: structure, regulation and function Nat. Rev. Neurosci. 4 2003 13 25 (Pubitemid 37271085)
49. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, Y.S. Ding, M. Sedler, J. Logan, D. Franceschi, J. Gatley, R. Hitzemann, A. Gifford, C. Wong, and N. Pappas Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex Am. J. Psychiatry 158 2001 2015 2021 (Pubitemid 33104107)
50. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, J. Logan, C. Wong, and E.N. Miller Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am. J. Psychiatry 158 2001 377 382 (Pubitemid 32205193)
51. Q.D. Walker, M.B. Rooney, R.M. Wightman, and C.M. Kuhn Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry Neuroscience 95 2000 1061 1070 (Pubitemid 30006894)
52. Y. Wei, J.M. Williams, C. Dipace, U. Sung, J.A. Javitch, A. Galli, and C. Saunders Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism Mol. Pharmacol. 71 2007 835 842 (Pubitemid 46294095)
53. J.M. Wilson, K.S. Kalasinsky, A.I. Levey, C. Bergeron, G. Reiber, R.M. Anthony, G.A. Schmunk, K. Shannak, J.W. Haycock, and S.J. Kish Striatal dopamine nerve terminal markers in human, chronic methamphetamine users Nat. Med. 2 1996 699 703 (Pubitemid 26191961)
54. T. Xie, L. Tong, T. Barrett, J. Yuan, G. Hatzidimitriou, U.D. McCann, K.G. Becker, D.M. Donovan, and G.A. Ricaurte Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity J. Neurosci. 22 2002 274 283 (Pubitemid 34033505)
55. L. Yu, and P.C. Liao Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice J. Neural Transm. 107 2000 419 427 (Pubitemid 30189415)
56. J.P. Zhu, W. Xu, and J.A. Angulo Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice Brain Res. 1049 2005 171 181 (Pubitemid 41072933)
57. J.P. Zhu, W. Xu, N. Angulo, and J.A. Angulo Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration Neurotoxicology 27 2006 131 136 (Pubitemid 41745016)